KLRS

Kalaris Therapeutics

52 hedge funds and large institutions have $24.6M invested in Kalaris Therapeutics in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$279K
2 +$232K
3 +$190K
4
Squarepoint
Squarepoint
New York
+$142K
5
UBS Group
UBS Group
Switzerland
+$51.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.99M
2
$4.71M
3
$3.95M
4
$2.77M
5
$1.27M
6
$1.11M
7
$801K
8
$279K
9
$266K
10
$246K
11
$232K
12
$209K
13
$190K
14
$168K
15
$159K
16
$142K
17
$136K
18
$134K
19
$112K
20
$104K
21
$77.4K
22
$67.1K
23
$64.5K
24
$52.7K
25
$51.7K